Department of Clinical Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.
Department of Acupuncture and Moxibustion Allergic Rhinitis, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.
J Tradit Chin Med. 2021 Feb;41(1):6-16. doi: 10.19852/j.cnki.jtcm.2021.01.002.
To evaluate the clinical efficacy and safety of combined acupuncture and Western Medicine in the treatment of post-stroke depression using a meta-analysis.
The China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, Chinese Biomedical Literature Database, PubMed, Embase, and the Cochrane Library were searched from their establishment to August 2018 for randomized controlled trials (RCTs) of combined acupuncture and Western Medicine to treat post-stroke depression. Two researchers independently extracted and cross-checked data, and then applied the modified Jadad scale and the Cochrane-recommended assessment method to evaluate the risk of bias. Review Manager 5.3 was used to conduct the meta-analysis.
A total of 1860 patients in 24 RCTs were analyzed. The results of the Meta-analysis showed that: (a) The effective rate of acupuncture + fluoxetine hydrochloride vs fluoxetine hydrochloride was significant [relative risk (RR) = 1.16, 95% confidence interval (CI) (1.08, 1.26)], as was that of acupuncture + flupentixol/melitracen vs flupentixol/melitracen [RR = 1.23, 95% CI (1.10, 1.37)]. (b) When analyzing Hamilton Depression Scale (HAMD)-17 scores, six trials showed that acupuncture combined with Western Medicine was superior to Western Medicine alone, and could relieve the depressive symptoms of patients. For HAMD-24 scores, five trials were included for acupuncture + fluoxetine hydrochloride vs fluoxetine hydrochloride, with significance at 2 weeks [WMD = -6.51, 95% CI(- 8.62, - 4.40)], as well as at 4 weeks [WMD = -8.40, 95% CI (-11.86, -4.94)] and 8 weeks. (c)For the activities of daily living scale, acupuncture + fluoxetine hydrochloride vs fluoxetine hydrochloride [WMD = 22.65, 95% CI (18.34, 26.95)], acupuncture + flupentixol/melitracen vs flupentixol/melitracen [WMD = 8.08, 95% CI (2.57, 13.59)], acupuncture + sertraline hydrochloride vs sertraline hydrochloride [WMD = 6.94, 95% CI (3.59, 10.29)], and acupuncture + doxepin hydrochloride vs doxepin hydrochloride [WMD = 18.80, 95% CI (15.84, 21.76)] had significance. (d) For Treatment Emergent Symptom Scale scores, there was significance in all four included studies.
The therapeutic effects of acupuncture combined with Western Medicine on post-stroke depression are often better than those of Western Medicine alone, and fewer adverse reactions occur. However, more high-quality RCTs are needed to further confirm these findings.
采用荟萃分析评价针刺联合西药治疗脑卒中后抑郁的临床疗效和安全性。
计算机检索中国知网、万方数据库、中国科技期刊数据库、中国生物医学文献数据库、PubMed、Embase、Cochrane 图书馆,搜集针刺联合西药治疗脑卒中后抑郁的随机对照试验(RCT),检索时限均从建库至 2018 年 8 月。由 2 名研究者独立筛选文献、提取资料并交叉核对,采用改良 Jadad 量表和 Cochrane 偏倚风险评价工具评价纳入研究的质量后,采用 Review Manager 5.3 软件进行 Meta 分析。
共纳入 24 个 RCT 涉及 1860 例患者。Meta 分析结果显示:①针刺+氟西汀组与氟西汀组比较,有效率[相对危险度(RR)=1.16,95%CI(1.08,1.26)]更高,针刺+氟哌噻吨美利曲辛组与氟哌噻吨美利曲辛组比较,有效率[RR=1.23,95%CI(1.10,1.37)]更高。②对汉密尔顿抑郁量表(HAMD)-17 评分的分析显示,6 项研究结果显示针刺联合西药治疗脑卒中后抑郁的疗效优于单纯西药治疗,可缓解患者的抑郁症状;对 HAMD-24 评分的分析显示,5 项研究结果显示针刺+氟西汀组与氟西汀组比较,2 周时[WMD=-6.51,95%CI(-8.62,-4.40)]、4 周时[WMD=-8.40,95%CI(-11.86,-4.94)]、8 周时[WMD=-8.40,95%CI(-11.86,-4.94)]差异均有统计学意义。③对日常生活能力量表的分析显示,针刺+氟西汀组与氟西汀组比较[WMD=22.65,95%CI(18.34,26.95)]、针刺+氟哌噻吨美利曲辛组与氟哌噻吨美利曲辛组比较[WMD=8.08,95%CI(2.57,13.59)]、针刺+舍曲林组与舍曲林组比较[WMD=6.94,95%CI(3.59,10.29)]、针刺+多塞平组与多塞平组比较[WMD=18.80,95%CI(15.84,21.76)]差异均有统计学意义。④对治疗中出现的症状量表评分的分析显示,4 项研究均显示差异有统计学意义。
针刺联合西药治疗脑卒中后抑郁的疗效常优于单纯西药治疗,且不良反应较少,但仍需要更多高质量的 RCT 进一步验证。